ingredients in semaglutide injection Semaglu-1 and reduced Ozempic® (semaglutide) GLP-1 RA for

Nausea is classified as 'very common' (affecting more than 1 in 10 people), occurring in approximately 15-20% of patients, whilst vomiting is 'common' (affecting up to 1 in 10 people), reported in around 5-9% of individuals taking the medication

Clinical Trial Results The most recent head-to-head study showed tirzepatide provided 47% greater relative weight loss compared to semaglutide

Methylcobalamin has an excellent safety profile with no established upper limit for toxicity

Prescription weight loss medications licensed in the UK include orlistat (Xenical, Alli), which blocks fat absorption in the gut and has no known direct interaction with fluoxetine